BackDecoy Therapeutics Overview

Decoy Therapeutics Accounts Payable

Decoy Therapeutics's accounts payable is $780K.

Get informed when a big investor buys or sells

+ Follow
Accounts Payable
$778612.00
↓ 29.49% YoYΔ $-325572.00 vs prior year quarter

Peer trimmed avg / median

Loading

Decoy Therapeutics Accounts Payable History

Loading

Decoy Therapeutics vs. peers: Accounts Payable Comparison

Loading

Decoy Therapeutics Accounts Payable Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Decoy Therapeutics (DCOY) FAQ

The latest accounts payable for DCOY is $780K as of September 2026. That compares with $1.1M in the prior-year period — down 29.5% year over year. Investors often review this figure alongside Decoy Therapeutics's historical trend and sector peers before judging valuation or financial health.

Over the past year, DCOY's accounts payable moved from $1.1M to $780K — a 29.5% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Decoy Therapeutics's operating scale or balance-sheet position.

A accounts payable figure of $780K for DCOY is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.

After noting DCOY's accounts payable ($780K), review year-over-year change from $1.1M, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.

This page's peer comparison chart is the fastest way to stack Decoy Therapeutics's accounts payable against similar Healthcare names. You can also browse sector and industry screens on Stockcircle for a broader set of Healthcare companies and their key multiples and fundamentals.